HRTX
Heron Therapeuti
0.3476$
-2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 57.9% | 28.9% | 24.4% | 29.2% | 28.8% | 25.1% | 21.7% | 26.5% | 40.3% | 18.8% | 30.6% | 30.7% | 29.9% | |
| 42.1% | 71.1% | 75.6% | 70.8% | 71.2% | 74.9% | 78.3% | 73.5% | 59.7% | 81.2% | 69.4% | 69.3% | 70.1% | |
| 43.1% | 32.0% | 13.3% | 12.3% | 13.6% | 7.8% | 5.9% | 7.9% | 9.1% | 9.2% | 6.9% | 7.2% | 8.1% | |
| 37.0% | 33.0% | 43.2% | 38.6% | 37.7% | 29.8% | 32.7% | 38.9% | 36.6% | 33.1% | 35.0% | 29.9% | 33.6% | |
| 121.4% | 101.0% | 89.5% | 88.7% | 84.8% | 64.7% | 70.2% | 77.9% | 70.5% | 81.1% | 83.1% | 74.7% | 77.3% | |
| -79.3% | -29.9% | -13.8% | -17.9% | -13.6% | 10.2% | 8.1% | -4.4% | -10.7% | 0.1% | -13.7% | -5.4% | -7.2% | |
| 1.8% | 6.3% | 1.6% | 1.1% | 1.5% | 10.9% | 1.3% | 1.3% | 7.6% | 2.5% | – | – | – | |
| -79.6% | -31.3% | -9.1% | -25.6% | -14.8% | 9.0% | 6.8% | -6.4% | -45.8% | -7.3% | -23.4% | -14.6% | -22.5% | |
| 2.4% | 0.9% | 1.9% | – | – | – | – | – | – | – | – | – | – | |
| -79.6% | -31.3% | -9.1% | -25.6% | -14.8% | 9.0% | 6.8% | -6.4% | -45.8% | -7.3% | -23.4% | -14.6% | -22.5% | |
| -75.5% | -16.3% | -5.5% | -22.7% | -11.5% | 21.4% | 9.5% | -4.8% | -36.6% | -2.0% | -21.8% | -14.6% | -18.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.